These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

3736 related articles for article (PubMed ID: 7346150)

  • 1. Heterogeneous in vitro sensitivities of metastatic B16 melanoma sublines and clones to retinoic acid or BCNU.
    Nicolson GL; Lotan R; Rios A
    Cancer Treat Rep; 1981; 65 Suppl 2():71-4. PubMed ID: 7346150
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heterogeneity in growth inhibition by beta-trans-retinoic acid of metastatic B16 melanoma clones and in vivo-selected cell variant lines.
    Lotan R; Nicolson GL
    Cancer Res; 1979 Dec; 39(12):4767-71. PubMed ID: 498105
    [No Abstract]   [Full Text] [Related]  

  • 3. Differential expression of a Mr approximately 90,000 cell surface transferrin receptor-related glycoprotein on murine B16 metastatic melanoma sublines selected for enhanced brain or ovary colonization.
    Nicolson GL; Inoue T; Van Pelt CS; Cavanaugh PG
    Cancer Res; 1990 Feb; 50(3):515-20. PubMed ID: 2297694
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the metastatic properties of B16 melanoma clones isolated from cultured cell lines, subcutaneous tumors, and individual lung metastases.
    Poste G; Doll J; Brown AE; Tzeng J; Zeidman I
    Cancer Res; 1982 Jul; 42(7):2770-8. PubMed ID: 7083167
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differences in cytotoxic effects of activated murine peritoneal macrophages and J774 monocytic cells on metastatic variants of B16 melanoma.
    Miner KM; Klostergaard J; Granger GA; Nicolson GL
    J Natl Cancer Inst; 1983 Apr; 70(4):717-24. PubMed ID: 6339778
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preferential organ attachment and invasion in vitro by B16 melanoma cells selected for differing metastatic colonization and invasive properties.
    Nicolson GL; Dulski K; Basson C; Welch DR
    Invasion Metastasis; 1985; 5(3):144-58. PubMed ID: 3997411
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The response of hypoxic B16 melanoma cells to in vivo treatment with chemotherapeutic agents.
    Hill RP; Stanley JA
    Cancer Res; 1975 May; 35(5):1147-53. PubMed ID: 1120304
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation of retinoic acid-enhanced sialyltransferase activity and glycosylation of specific cell surface sialoglycoproteins with growth inhibition in a murine melanoma cell system.
    Lotan R; Lotan D; Meromsky L
    Cancer Res; 1984 Dec; 44(12 Pt 1):5805-12. PubMed ID: 6498840
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differences in drug sensitivity among tumor cells from parental tumors, selected variants, and spontaneous metastases.
    Tsuruo T; Fidler IJ
    Cancer Res; 1981 Aug; 41(8):3058-64. PubMed ID: 7248962
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of retinoids on growth and melanin content of Harding-Passey-melanoma cells in vitro and B16 transplantable melanoma in vivo.
    Drewa G; Schachtschabel DO
    Arch Geschwulstforsch; 1985; 55(2):93-8. PubMed ID: 4004512
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro selection of murine B16 melanoma variants with enhanced tissue-invasive properties.
    Poste G; Doll J; Hart IR; Fidler IJ
    Cancer Res; 1980 May; 40(5):1636-44. PubMed ID: 7370995
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clonal drift of cell surface, melanogenic, and experimental metastatic properties of in vivo-selected, brain meninges-colonizing murine B16 melanoma.
    Miner KM; Kawaguchi T; Uba GW; Nicolson GL
    Cancer Res; 1982 Nov; 42(11):4631-8. PubMed ID: 7127301
    [No Abstract]   [Full Text] [Related]  

  • 13. Heterogeneity of protein phosphorylation in metastatic variants of B16 melanoma.
    Greig RG; Caltabiano L; Reid R; Feild J; Poste G
    Cancer Res; 1983 Dec; 43(12 Pt 1):6057-65. PubMed ID: 6640547
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of glycoconjugates in metastatic melanoma blood-borne arrest and cell surface properties.
    Irimura T; Nicolson GL
    J Supramol Struct Cell Biochem; 1981; 17(4):325-36. PubMed ID: 7328676
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Growth support of small B16 melanoma implants with nitrosourea-sterilized fractions of the same tumor.
    Dykes DJ; Griswold DP; Schabel FM
    Cancer Res; 1976 Jun; 36(6):2031-4. PubMed ID: 1268854
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enforced expression of MCAM/MUC18 increases in vitro motility and invasiveness and in vivo metastasis of two mouse melanoma K1735 sublines in a syngeneic mouse model.
    Wu GJ; Fu P; Wang SW; Wu MW
    Mol Cancer Res; 2008 Nov; 6(11):1666-77. PubMed ID: 19010815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Paracrine growth response as a major determinant in liver-specific colonization by in vivo selected B16 murine melanoma cells.
    Rusciano D; Lorenzoni P; Burger MM
    Invasion Metastasis; 1993; 13(4):212-24. PubMed ID: 8034443
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of genes differentially expressed in B16 murine melanoma sublines with different metastatic potentials.
    Ishiguro T; Nakajima M; Naito M; Muto T; Tsuruo T
    Cancer Res; 1996 Feb; 56(4):875-9. PubMed ID: 8631027
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differences in the sensitivities of murine metastatic lymphoma/lymphosarcoma variants to macrophage-mediated cytolysis and/or cytostasis.
    Miner KM; Nicolson GL
    Cancer Res; 1983 May; 43(5):2063-7. PubMed ID: 6687559
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation of the production of plasminogen activator with tumor metastasis in B16 mouse melanoma cell lines.
    Wang BS; McLoughlin GA; Richie JP; Mannick JA
    Cancer Res; 1980 Feb; 40(2):288-92. PubMed ID: 7356511
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 187.